1391 related articles for article (PubMed ID: 36607335)
1. Multimodal brain age estimates relate to Alzheimer disease biomarkers and cognition in early stages: a cross-sectional observational study.
Millar PR; Gordon BA; Luckett PH; Benzinger TLS; Cruchaga C; Fagan AM; Hassenstab JJ; Perrin RJ; Schindler SE; Allegri RF; Day GS; Farlow MR; Mori H; Nübling G; ; Bateman RJ; Morris JC; Ances BM
Elife; 2023 Jan; 12():. PubMed ID: 36607335
[TBL] [Abstract][Full Text] [Related]
2. Predicting brain age from functional connectivity in symptomatic and preclinical Alzheimer disease.
Millar PR; Luckett PH; Gordon BA; Benzinger TLS; Schindler SE; Fagan AM; Cruchaga C; Bateman RJ; Allegri R; Jucker M; Lee JH; Mori H; Salloway SP; Yakushev I; Morris JC; Ances BM;
Neuroimage; 2022 Aug; 256():119228. PubMed ID: 35452806
[TBL] [Abstract][Full Text] [Related]
3. MRI predictors of amyloid pathology: results from the EMIF-AD Multimodal Biomarker Discovery study.
Ten Kate M; Redolfi A; Peira E; Bos I; Vos SJ; Vandenberghe R; Gabel S; Schaeverbeke J; Scheltens P; Blin O; Richardson JC; Bordet R; Wallin A; Eckerstrom C; Molinuevo JL; Engelborghs S; Van Broeckhoven C; Martinez-Lage P; Popp J; Tsolaki M; Verhey FRJ; Baird AL; Legido-Quigley C; Bertram L; Dobricic V; Zetterberg H; Lovestone S; Streffer J; Bianchetti S; Novak GP; Revillard J; Gordon MF; Xie Z; Wottschel V; Frisoni G; Visser PJ; Barkhof F
Alzheimers Res Ther; 2018 Sep; 10(1):100. PubMed ID: 30261928
[TBL] [Abstract][Full Text] [Related]
4. Advanced structural brain aging in preclinical autosomal dominant Alzheimer disease.
Millar PR; Gordon BA; Wisch JK; Schultz SA; Benzinger TL; Cruchaga C; Hassenstab JJ; Ibanez L; Karch C; Llibre-Guerra JJ; Morris JC; Perrin RJ; Supnet-Bell C; Xiong C; Allegri RF; Berman SB; Chhatwal JP; Chrem Mendez PA; Day GS; Hofmann A; Ikeuchi T; Jucker M; Lee JH; Levin J; Lopera F; Niimi Y; Sánchez-González VJ; Schofield PR; Sosa-Ortiz AL; Vöglein J; ; Bateman RJ; Ances BM; McDade EM
Mol Neurodegener; 2023 Dec; 18(1):98. PubMed ID: 38111006
[TBL] [Abstract][Full Text] [Related]
5. Tau PET in autosomal dominant Alzheimer's disease: relationship with cognition, dementia and other biomarkers.
Gordon BA; Blazey TM; Christensen J; Dincer A; Flores S; Keefe S; Chen C; Su Y; McDade EM; Wang G; Li Y; Hassenstab J; Aschenbrenner A; Hornbeck R; Jack CR; Ances BM; Berman SB; Brosch JR; Galasko D; Gauthier S; Lah JJ; Masellis M; van Dyck CH; Mintun MA; Klein G; Ristic S; Cairns NJ; Marcus DS; Xiong C; Holtzman DM; Raichle ME; Morris JC; Bateman RJ; Benzinger TLS
Brain; 2019 Apr; 142(4):1063-1076. PubMed ID: 30753379
[TBL] [Abstract][Full Text] [Related]
6. MRI or
Doering E; Antonopoulos G; Hoenig M; van Eimeren T; Daamen M; Boecker H; Jessen F; Düzel E; Eickhoff S; Patil K; Drzezga A;
J Nucl Med; 2024 Jan; 65(1):147-155. PubMed ID: 38050112
[TBL] [Abstract][Full Text] [Related]
7. Combining magnetoencephalography with magnetic resonance imaging enhances learning of surrogate-biomarkers.
Engemann DA; Kozynets O; Sabbagh D; Lemaître G; Varoquaux G; Liem F; Gramfort A
Elife; 2020 May; 9():. PubMed ID: 32423528
[TBL] [Abstract][Full Text] [Related]
8. The Brain Chart of Aging: Machine-learning analytics reveals links between brain aging, white matter disease, amyloid burden, and cognition in the iSTAGING consortium of 10,216 harmonized MR scans.
Habes M; Pomponio R; Shou H; Doshi J; Mamourian E; Erus G; Nasrallah I; Launer LJ; Rashid T; Bilgel M; Fan Y; Toledo JB; Yaffe K; Sotiras A; Srinivasan D; Espeland M; Masters C; Maruff P; Fripp J; Völzk H; Johnson SC; Morris JC; Albert MS; Miller MI; Bryan RN; Grabe HJ; Resnick SM; Wolk DA; Davatzikos C;
Alzheimers Dement; 2021 Jan; 17(1):89-102. PubMed ID: 32920988
[TBL] [Abstract][Full Text] [Related]
9. Brain properties predict proximity to symptom onset in sporadic Alzheimer's disease.
Vogel JW; Vachon-Presseau E; Pichet Binette A; Tam A; Orban P; La Joie R; Savard M; Picard C; Poirier J; Bellec P; Breitner JCS; Villeneuve S;
Brain; 2018 Jun; 141(6):1871-1883. PubMed ID: 29688388
[TBL] [Abstract][Full Text] [Related]
10. Utility of an Alzheimer's Disease Risk-Weighted Polygenic Risk Score for Predicting Rates of Cognitive Decline in Preclinical Alzheimer's Disease: A Prospective Longitudinal Study.
Porter T; Burnham SC; Milicic L; Savage G; Maruff P; Lim YY; Li QX; Ames D; Masters CL; Rainey-Smith S; Rowe CC; Salvado O; Groth D; Verdile G; Villemagne VL; Laws SM;
J Alzheimers Dis; 2018; 66(3):1193-1211. PubMed ID: 30412495
[TBL] [Abstract][Full Text] [Related]
11. The metabolic brain signature of cognitive resilience in the 80+: beyond Alzheimer pathologies.
Arenaza-Urquijo EM; Przybelski SA; Lesnick TL; Graff-Radford J; Machulda MM; Knopman DS; Schwarz CG; Lowe VJ; Mielke MM; Petersen RC; Jack CR; Vemuri P
Brain; 2019 Apr; 142(4):1134-1147. PubMed ID: 30851100
[TBL] [Abstract][Full Text] [Related]
12. Diagnosis and prognosis of Alzheimer's disease using brain morphometry and white matter connectomes.
Wang Y; Xu C; Park JH; Lee S; Stern Y; Yoo S; Kim JH; Kim HS; Cha J;
Neuroimage Clin; 2019; 23():101859. PubMed ID: 31150957
[TBL] [Abstract][Full Text] [Related]
13. Investigating the temporal pattern of neuroimaging-based brain age estimation as a biomarker for Alzheimer's Disease related neurodegeneration.
Taylor A; Zhang F; Niu X; Heywood A; Stocks J; Feng G; Popuri K; Beg MF; Wang L;
Neuroimage; 2022 Nov; 263():119621. PubMed ID: 36089183
[TBL] [Abstract][Full Text] [Related]
14. Cognitive and neuroimaging features and brain β-amyloidosis in individuals at risk of Alzheimer's disease (INSIGHT-preAD): a longitudinal observational study.
Dubois B; Epelbaum S; Nyasse F; Bakardjian H; Gagliardi G; Uspenskaya O; Houot M; Lista S; Cacciamani F; Potier MC; Bertrand A; Lamari F; Benali H; Mangin JF; Colliot O; Genthon R; Habert MO; Hampel H;
Lancet Neurol; 2018 Apr; 17(4):335-346. PubMed ID: 29500152
[TBL] [Abstract][Full Text] [Related]
15. Clinical and cognitive trajectories in cognitively healthy elderly individuals with suspected non-Alzheimer's disease pathophysiology (SNAP) or Alzheimer's disease pathology: a longitudinal study.
Burnham SC; Bourgeat P; Doré V; Savage G; Brown B; Laws S; Maruff P; Salvado O; Ames D; Martins RN; Masters CL; Rowe CC; Villemagne VL;
Lancet Neurol; 2016 Sep; 15(10):1044-53. PubMed ID: 27450471
[TBL] [Abstract][Full Text] [Related]
16. ApoE4 effects on automated diagnostic classifiers for mild cognitive impairment and Alzheimer's disease.
Apostolova LG; Hwang KS; Kohannim O; Avila D; Elashoff D; Jack CR; Shaw L; Trojanowski JQ; Weiner MW; Thompson PM;
Neuroimage Clin; 2014; 4():461-72. PubMed ID: 24634832
[TBL] [Abstract][Full Text] [Related]
17. Structural magnetic resonance imaging for the early diagnosis of dementia due to Alzheimer's disease in people with mild cognitive impairment.
Lombardi G; Crescioli G; Cavedo E; Lucenteforte E; Casazza G; Bellatorre AG; Lista C; Costantino G; Frisoni G; Virgili G; Filippini G
Cochrane Database Syst Rev; 2020 Mar; 3(3):CD009628. PubMed ID: 32119112
[TBL] [Abstract][Full Text] [Related]
18. Accelerated inflammatory aging in Alzheimer's disease and its relation to amyloid, tau, and cognition.
Cullen NC; Mälarstig AN; Stomrud E; Hansson O; Mattsson-Carlgren N
Sci Rep; 2021 Jan; 11(1):1965. PubMed ID: 33479445
[TBL] [Abstract][Full Text] [Related]
19. Nonlinear changes in delayed functional network topology in Alzheimer's disease: relationship with amyloid and tau pathology.
Mijalkov M; Veréb D; Canal-Garcia A; Hinault T; Volpe G; Pereira JB;
Alzheimers Res Ther; 2023 Jun; 15(1):112. PubMed ID: 37328909
[TBL] [Abstract][Full Text] [Related]
20. Utility of Plasma Neurofilament Light in the 1Florida Alzheimer's Disease Research Center (ADRC).
Barker W; Quinonez C; Greig MT; Behar R; Chirinos C; Rodriguez RA; Rosselli M; Rodriguez MJ; Cid RC; Rundek T; McFarland K; Hanson K; Smith G; DeKosky S; Vaillancourt D; Adjouadi M; Marsiske M; Ertekin-Taner N; Golde T; Loewenstein DA; Duara R
J Alzheimers Dis; 2021; 79(1):59-70. PubMed ID: 33216030
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
